These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 9835423)
1. Non-Invasive Delivery of Negatively Charged Nanobodies by Anodal Iontophoresis: When Electroosmosis Dominates Electromigration. Sahraoui PF; Vadas O; Kalia YN Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675200 [TBL] [Abstract][Full Text] [Related]
2. Membrane Protein Stabilization Strategies for Structural and Functional Studies. Errasti-Murugarren E; Bartoccioni P; Palacín M Membranes (Basel); 2021 Feb; 11(2):. PubMed ID: 33671740 [TBL] [Abstract][Full Text] [Related]
3. Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy. Hu Y; Liu C; Muyldermans S Front Immunol; 2017; 8():1442. PubMed ID: 29163515 [TBL] [Abstract][Full Text] [Related]
4. Extracellular Expression in Aspergillus niger of an Antibody Fused to Leishmania sp. Antigens. Magaña-Ortíz D; Fernández F; Loske AM; Gómez-Lim MA Curr Microbiol; 2018 Jan; 75(1):40-48. PubMed ID: 28861662 [TBL] [Abstract][Full Text] [Related]
5. Nanobodies to Study G Protein-Coupled Receptor Structure and Function. Manglik A; Kobilka BK; Steyaert J Annu Rev Pharmacol Toxicol; 2017 Jan; 57():19-37. PubMed ID: 27959623 [TBL] [Abstract][Full Text] [Related]
6. Expression of recombinant antibodies. Frenzel A; Hust M; Schirrmann T Front Immunol; 2013; 4():217. PubMed ID: 23908655 [TBL] [Abstract][Full Text] [Related]
7. Cost-effective HRMA pre-sequence typing of clone libraries; application to phage display selection. Pepers BA; Schut MH; Vossen RH; van Ommen GJ; den Dunnen JT; van Roon-Mom WM BMC Biotechnol; 2009 May; 9():50. PubMed ID: 19463169 [TBL] [Abstract][Full Text] [Related]
8. Transcriptomic comparison of Aspergillus niger growing on two different sugars reveals coordinated regulation of the secretory pathway. Jørgensen TR; Goosen T; Hondel CA; Ram AF; Iversen JJ BMC Genomics; 2009 Jan; 10():44. PubMed ID: 19166577 [TBL] [Abstract][Full Text] [Related]
9. Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120. Forsman A; Beirnaert E; Aasa-Chapman MM; Hoorelbeke B; Hijazi K; Koh W; Tack V; Szynol A; Kelly C; McKnight A; Verrips T; de Haard H; Weiss RA J Virol; 2008 Dec; 82(24):12069-81. PubMed ID: 18842738 [TBL] [Abstract][Full Text] [Related]
10. Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo. Dolk E; van der Vaart M; Lutje Hulsik D; Vriend G; de Haard H; Spinelli S; Cambillau C; Frenken L; Verrips T Appl Environ Microbiol; 2005 Jan; 71(1):442-50. PubMed ID: 15640220 [TBL] [Abstract][Full Text] [Related]
11. Characterization of humanized antibodies secreted by Aspergillus niger. Ward M; Lin C; Victoria DC; Fox BP; Fox JA; Wong DL; Meerman HJ; Pucci JP; Fong RB; Heng MH; Tsurushita N; Gieswein C; Park M; Wang H Appl Environ Microbiol; 2004 May; 70(5):2567-76. PubMed ID: 15128505 [TBL] [Abstract][Full Text] [Related]
12. The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Joosten V; Lokman C; Van Den Hondel CA; Punt PJ Microb Cell Fact; 2003 Jan; 2(1):1. PubMed ID: 12605725 [TBL] [Abstract][Full Text] [Related]
13. Filamentous fungi as production organisms for glycoproteins of bio-medical interest. Maras M; van Die I; Contreras R; van den Hondel CA Glycoconj J; 1999 Feb; 16(2):99-107. PubMed ID: 10612410 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms. Frenken LG; Hessing JG; Van den Hondel CA; Verrips CT Res Immunol; 1998; 149(6):589-99. PubMed ID: 9835423 [No Abstract] [Full Text] [Related]
15. Rabbit monoclonal Fab derived from a phage display library. Foti M; Granucci F; Ricciardi-Castagnoli P; Spreafico A; Ackermann M; Suter M J Immunol Methods; 1998 Apr; 213(2):201-12. PubMed ID: 9692852 [TBL] [Abstract][Full Text] [Related]
16. Methods for generating multivalent and bispecific antibody fragments. Tomlinson I; Holliger P Methods Enzymol; 2000; 326():461-79. PubMed ID: 11036658 [No Abstract] [Full Text] [Related]
17. Production of antibody fragments in a bioreactor. Hellebust H Methods Mol Biol; 2003; 207():437-41. PubMed ID: 12412490 [No Abstract] [Full Text] [Related]
18. The next generation of antibodies: production of recombinant antibodies or fragments derived thereof. de Geus B Res Immunol; 1998; 149(6):587-9. PubMed ID: 9835422 [No Abstract] [Full Text] [Related]